Evidence map›Paper›PMID 19377070›Full record

ArticleCardiovascular research2009

Readthrough of nonsense mutation W822X in the SCN5A gene can effectively restore expression of cardiac Na+ channels.

Siyong Teng, Lizhi Gao, Vesa Paajanen, Jielin Pu, Zheng Fan

Open access · bronzeAbstract read
In one paragraph

Article in Cardiovascular research, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.5field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 30 citations in OpenAlex.

  1. SCN5A variant type-dependent risk prediction in Brugada syndrome.Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology · 2025
    Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Novel SCN5A mutations in two families with "Brugada-like" ST elevation in the inferior leads and conduction disturbances.Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing · 2013
    Article
  8. The genetic component of Brugada syndrome.Frontiers in physiology · 2013
    Article
  9. Article
  10. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

Siyong TengCardiovascular Institute and Fuwai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Lizhi Gao
Vesa Paajanen
Jielin Pu
Zheng Fan
University of Tennessee Health Science Center · USChinese Academy of Medical Sciences & Peking Union Medical College · CNPeking Union Medical College Hospital · CN

Funding

Phosphoinositides and ATP-sensitive K+ channels in heartR01HL058133 · NHLBI · UNIVERSITY OF TENNESSEE HEALTH SCI CTR · PI FAN, ZHENG · 2003 to 2006
$1.2M
ATP BLOCK SENSITIVE POTASSIUM CHANNELS IN HEARTR29HL058133 · NHLBI · UNIVERSITY OF WISCONSIN MADISON · PI FAN, ZHENG · 1997 to 2000
$101k
NHLBI NIH HHS HL-58133
6 · The paper itself

Abstract

aimsNonsense mutations in the SCN5A gene result in truncated, non-functional derivatives of the cardiac Na+ channel and thus cause arrhythmias. Studies of other genes suggest that pathogenic phenotypes of nonsense mutations may be alleviated by enhancing readthrough, which enables ribosomes to ignore premature termination codons and produce full-length proteins. Thus, we studied the functional restoration of nonsense-mutated SCN5A. METHODS AND

resultsHEK293 cells were transfected with SCN5A cDNA or its mutant carrying W822X, a nonsense mutation associated with Brugada syndrome and sudden cardiac death. The effects of readthrough-enhancing reagents on Na+ channel expression and function were examined in the transfected cells. W822X robustly reduced Na+ current, decreasing maximal Na+ current to <3% of the wild-type level, and inhibited the expression of full-length Na+ channels. When readthrough was enhanced by either reducing translational fidelity with aminoglycosides or decreasing translation termination efficiency with small-interfering RNA against eukaryotic release factor eRF3a, Na+ current of the mutant was restored to approximately 30% of the wild-type level; western blot and immunochemical staining analyses showed the increased expression of full-length channels. When the wild-type and mutant cDNAs were co-transfected, readthrough-enhancing reagents increased Na+ current from 56% to 74% of the wild-type level. Analysis of Na+ channel kinetics showed that the channels expressed from the mutant cDNA under readthrough-enhancing conditions retained the functions of wild-type channels.

conclusionReadthrough-enhancing reagents can effectively suppress SCN5A nonsense mutations and may restore the expression of full-length Na+ channels with normal functions, which might prevent sudden cardiac death in mutation carriers.

Indexed as

Codon, NonsenseRNA InterferenceAminoglycosidesBrugada SyndromeCell LineCodon, TerminatorDeath, Sudden, CardiacGenotypeHumansKineticsMembrane PotentialsMuscle ProteinsMyocytes, CardiacNAV1.5 Voltage-Gated Sodium ChannelPeptide Termination FactorsPhenotypeAminoglycosidesCodon, NonsenseCodon, TerminatorMuscle ProteinsNAV1.5 Voltage-Gated Sodium Channelpeptide-chain-release factor 3Peptide Termination FactorsRNA, Small InterferingSCN5A protein, humanSodiumSodium Channels

Identifiers

PMID19377070
PMCPMC2709462
OpenAlexW2165593572

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.